PATENT CLAIM ANALYSIS

Application Number: 16086143
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "252160"]

Abstract:
Provided herein are compositions and methods for treating or preventing metabolic disorders. In particular, provided herein are compositions, methods, and uses of Cyclin-dependent Kinase 6 (CDK6) inhibitors for treating and preventing metabolic diseases (e.g., type II diabetes, obesity, metabolic syndrome, elevated blood pressure, cardiovascular diseases, elevated fasting plasma glucose, and high serum triglycerides).

Claim (Index 5):
The method of  claim 1 , wherein said metabolic disease is selected from the group consisting of type II diabetes, obesity, metabolic syndrome, elevated blood pressure, cardiovascular diseases, elevated fasting plasma glucose, and high serum triglycerides.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 97.0
- Lexical Diversity: 1.60465
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14778379', '13698385', '14021825', '14389374', '14376209']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7989143620333742
- 35 USC 102 Novelty (BERT): 0.4899015307867641
- Combined Prediction Score: 0.7680130789087132
- Mean Citation Score: 237.85321
- Max Citation Score: 250.6277
- Similarity Product: 206.993153100878

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test